Dieckol and Its Derivatives as Potential Inhibitors of SARS-CoV-2 Spike Protein (UK Strain: VUI 202012/01): A Computational Study
The high risk of morbidity and mortality associated with SARS-CoV-2 has accelerated the development of many potential vaccines. However, these vaccines are designed against SARS-CoV-2 isolated in Wuhan, China, and thereby may not be effective against other SARS-CoV-2 variants such as the United King...
Main Authors: | Mohammad Aatif, Ghazala Muteeb, Abdulrahman Alsultan, Adil Alshoaibi, Bachir Yahia Khelif |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-3397/19/5/242 |
Similar Items
-
Leaves of <i>Moringa oleifera</i> Are Potential Source of Bioactive Compound β-Carotene: Evidence from In Silico and Quantitative Gene Expression Analysis
by: Ghazala Muteeb, et al.
Published: (2023-02-01) -
SARS-CoV-2 variant VUI 202012/01 (B.1.1.7) in a pediatric patient: first case report in Ecuador
by: Jaime David Acosta España, et al.
Published: (2021-04-01) -
Seaweeds Compounds: An Ecosustainable Source of Cosmetic Ingredients?
by: Tiago Morais, et al.
Published: (2021-01-01) -
Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach
by: Ghazala Muteeb, et al.
Published: (2022-02-01) -
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
by: Frederic Grabowski, et al.
Published: (2021-03-01)